The opinion magazine of the American Gastroenterological Association
This is half of a two-part debate — read the opposing argument. Recurrent bleeding, along with advanced age and medical co-morbidities, is an independent predictor of mortality in patients with upper gastrointestinal (GI) hemorrhage. Although we as endoscopists cannot alter the patient’s age or their comorbidities, we may be able to reduce the risk of […]
This is half of a two-part debate — read the opposing argument. Why use Doppler endoscopic probe (DEP) in the management of severe non-variceal gastrointestinal hemorrhage (NVUGIH)? The fundamental reason is that DEP gives endoscopists a new dimension to help them treat patients: the ability to monitor arterial blood flow underneath stigmata of recent hemorrhage […]
The AGA Research Foundation offers its flagship grant, the AGA Research Scholar Award, to the most promising early career investigators. Kyle Staller, MD, MPH, an assistant professor of medicine at Harvard Medical School in Boston, is no exception. We’re thrilled to highlight Dr. Staller— a2016 AGA Research Scholar Award winner—as our AGA Research Foundation researcher […]
In April 2019, the AGA Center for GI Innovation and Technology hosted its annual meeting, the AGA Tech Summit. It was the summit’s 10th anniversary, and we celebrated with fantastic presentations and networking. As always, this year’s Shark Tank was a highlight of the AGA Tech Summit and represents the progress our field is making […]
Hashem B. El-Serag, MD, MPH, AGAF, began his term as the 114th president of the AGA Institute during Digestive Disease Week® (DDW) 2019. Dr. El-Serag is former editor-in-chief of AGA’s journal Clinical Gastroenterology and Hepatology. He currently serves as chair of the department of medicine at Baylor College of Medicine, Houston, Texas, following a decade […]
Nonalcoholic fatty liver disease (NAFLD) is a common condition, affecting as many as 30 percent of the U.S. population. Thus, every third person walking down the street may have NAFLD. Most of these individuals will live with NAFLD but die of other conditions, with heart disease being at the top of the list. However, some […]
Introduction The topic of unconscious bias has risen to the forefront of conversations in academic medicine. At Digestive Disease Week (DDW) 2019, the AGA Diversity Committee sponsored a symposium for our members to join the discussion. With a focus on patient care, we pose the question: Does race impact the health of the communities we […]
Preamble to this article: I did not volunteer to write this opinion paper, but was asked by the outgoing editor, Dr. Gary Falk. Why, I’m not sure, because I don’t have this technology in our Esophageal Center at the University of South Florida. On the other hand, I am a seasoned esophagologist and motility expert, […]
Esophageal symptoms are common and affect at least a quarter of the population. There are a multitude of diagnostic tests available, but no true gold standard and each test is complementary. Endoscopy allows direct visualization of the mucosa, biopsy acquisition and potential dilation — but does not directly assess motility, biomechanical properties or bolus transit. […]
A recent case in the forum involves a patient with cirrhosis and a MELD-Na of 7 who presents for evaluation of uncontrolled hepatic encephalopathy. The current medication regimen includes lactulose titrated to three bowel movements per day, rifaximin 550 mg BID and zinc 220 mg BID. The patient continues to report symptoms of forgetfulness and […]
Stay Connected